CRON Stock Summary and Trading Ideas (Cronos Group - Common Share | NASDAQ:CRON)

Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.

Cronos Group - Common Share trades on the NASDAQ stock market under the symbol CRON.

As of January 31, 2025, CRON stock price declined to $1.89 with 1,106,029 million shares trading.

CRON has a beta of 0.96, meaning it tends to be less sensitive to market movements. CRON has a correlation of 0.09 to the broad based SPY ETF.

CRON has a market cap of $722.00 million. This is considered a Small Cap stock.

Last quarter Cronos Group - Common Share reported $34 million in Revenue and $.02 earnings per share. This beat revenue expectation by $5 million and exceeded earnings estimates by $.03.

In the last 3 years, CRON traded as high as $4.31 and as low as $1.64.

The top ETF exchange traded funds that CRON belongs to (by Net Assets): YOLO, TOKE, DFIS, ONEQ, DFIC.

CRON has underperformed the market in the last year with a price return of -5.5% while the SPY ETF gained +24.0%. CRON has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -10.4% and -4.1%, respectively, while the SPY returned +4.1% and +1.7%, respectively.

CRON support price is $1.89 and resistance is $1.97 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CRON shares will trade within this expected range on the day.